Compound Summary
L-glutamine
Compound Information
L-glutamine
Compound Name: | L-glutamine |
Compound CID: | 5961 |
Synonyms: | L-glutamine glutamine 56-85-9 Levoglutamide L-(+)-Glutamine More... |
Iupac Name: | (2S)-2,5-diamino-5-oxopentanoic acid |
InChI: | InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1 |
InChIKey: | ZDXPYRJPNDTMRX-VKHMYHEASA-N |
Canonical Smiles: | C(CC(=O)N)C(C(=O)O)N |
Isomeric Smiles: | C(CC(=O)N)[C@@H](C(=O)O)N |
Molecular Weight: | 146.14 |
Molecular Formula: | C5H10N2O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-glutamine
Molecular Weight: | 146.14 |
Molecular Formula: | C5H10N2O3 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 10 |
Complexity: | 146 |
Synonyms
L-glutamine
| L-glutamine | L-glutamine |
|---|---|
L-glutamine |
glutamine |
56-85-9 |
Levoglutamide |
L-(+)-Glutamine |
Glutamic acid amide |
H-Gln-OH |
Stimulina |
Cebrogen |
(S)-2,5-Diamino-5-oxopentanoic acid |
glumin |
Levoglutamid |
Glavamin |
glutamic acid 5-amide |
L-Glutamide |
2-aminoglutaramic acid |
Miglu-P |
Polyglutamine |
Saforis |
L-2-Aminoglutaramidic acid |
L-Glutamic acid gamma-amide |
L-Glutamin |
Glumin (amino acid) |
(2S)-2-amino-4-carbamoylbutanoic acid |
Glutamine (VAN) |
L-2-Aminoglutaramic acid |
L-Glutamic acid 5-amide |
Levoglutamida |
Levoglutamidum |
2-Aminoglutaramic acid, L- |
(2S)-2,5-diamino-5-oxopentanoic acid |
FEMA No. 3684 |
Levoglutamidum INN-Latin |
Levoglutamida INN-Spanish |
Nutrestore |
Levoglutamina |
Pentanoic acid, 2,5-diamino-5-oxo-, (S)- |
GLUTAMINE, L- |
L-Glutamid |
2,5-Diamino-5-oxopentanoic acid, (S)- |
AI3-24392 |
d(-)-glutamine |
NSC 27421 |
UNII-0RH81L854J |
BRN 1723797 |
L-Glutaminsaeure-5-amid |
MFCD00008044 |
CHEMBL930 |
CHEBI:18050 |
0RH81L854J |
gln |
L-gln |
GLUTAMINE (D) |
Glutamine (L-Glutamine) |
Poly(glutamine) |
Levoglutamide DCF:INN |
26700-71-0 |
gamma-Glutamine |
.gamma.-Glutamine |
L-Glutamine-13C5 |
Glutamine USAN |
(2S)-2,5-diamino-5-oxopentanoate |
184161-19-1 |
GLUTAMINE (L) |
EINECS 200-292-1 |
L-Glutamic acid .gamma.-amide |
Glutamine USAN:USP:INN |
laevo-glutamine |
CCRIS 9428 |
NSC-27421 |
3h-l-glutamine |
HSDB 8165 |
1wdn |
(S)-glutamine |
3Hglutamine |
Nutrestore (TN) |
S(+)Glutamine |
Glutamine (USP) |
14Cglutamine |
3H-glutamine |
L-Glutamine Powder |
Cebrogen, Stimulina |
L-Glutamine,(S) |
S(+)-Glutamine |
14C-glutamine |
Ala-Gln-OH |
H-Gln |
Endari (TN) |
L-Alanyl-L-glutamide |
Spectrum_000131 |
L-Glutamine JAN |
SpecPlus_000380 |
L-Glutamine (JP17) |
L-Glutamine, homopolymer |
L-Glutamine-13C5 |
Spectrum2_001377 |
Spectrum3_001416 |
Spectrum4_001709 |
Spectrum5_000418 |
L-Glutamine, 98.5% |
bmse000038 |
bmse001014 |
SCHEMBL7453 |
Lopac0_000549 |
BSPBio_003092 |
GTPL723 |
KBioGR_002038 |
KBioSS_000591 |
4-04-00-03038 (Beilstein Handbook Reference) |
DivK1c_006476 |
SPECTRUM1500987 |
N-(2)-L-alanyl-L-glutamine |
S(+)-Glutamic acid 5-amide |
SPBio_001334 |
L-3,4-3H(N)glutamine |
GTPL4633 |
GTPL4634 |
DTXSID1023100 |
SCHEMBL19240116 |
SCHEMBL23124227 |
BDBM18121 |
KBio1_001420 |
KBio2_000591 |
KBio2_003159 |
KBio2_005727 |
KBio3_002312 |
HMS3261N19 |
HMS3264C03 |
L-Glutamine, Cell Culture Reagent |
Pharmakon1600-01300018 |
Pharmakon1600-01500987 |
(S)-2,5-Diamino-5-oxopentanoate |
HY-N0390 |
ZINC1532526 |
(2S)-2-amino-4-carbamoylbutanoate |
Tox21_500549 |
CCG-38853 |
EBD968977 |
NSC759628 |
NSC760081 |
s1749 |
AKOS015854078 |
(S)-2-Amino-4-carbamoyl-butyric acid |
AM81759 |
CS-1947 |
DB00130 |
LP00549 |
MCULE-8718820108 |
NSC-759628 |
NSC-760081 |
SDCCGMLS-0066691.P001 |
SDCCGSBI-0050532.P005 |
NCGC00093936-01 |
NCGC00093936-02 |
NCGC00093936-03 |
NCGC00093936-04 |
NCGC00093936-05 |
NCGC00093936-15 |
NCGC00261234-01 |
(2S)-2,5-diamino-5-oxo-pentanoic acid |
AS-11765 |
BP-13284 |
SBI-0050532.P003 |
AB0004431 |
L-Glutamine, BioUltra, >=99.5% (NT) |
EU-0100549 |
G0063 |
L-Glutamine, SAJ special grade, >=99.0% |
C00064 |
D00015 |
D70833 |
G 3126 |
M02960 |
16575-EP2269996A1 |
16575-EP2270004A1 |
16575-EP2275412A1 |
16575-EP2277861A1 |
16575-EP2277876A1 |
16575-EP2281563A1 |
16575-EP2281815A1 |
16575-EP2281824A1 |
16575-EP2284157A1 |
16575-EP2284171A1 |
16575-EP2286812A1 |
16575-EP2289876A1 |
16575-EP2289883A1 |
16575-EP2289892A1 |
16575-EP2289893A1 |
16575-EP2292611A1 |
16575-EP2292614A1 |
16575-EP2295055A2 |
16575-EP2295401A2 |
16575-EP2295411A1 |
16575-EP2295416A2 |
16575-EP2295417A1 |
16575-EP2295429A1 |
16575-EP2298312A1 |
16575-EP2298748A2 |
16575-EP2298780A1 |
16575-EP2301533A1 |
16575-EP2301940A1 |
16575-EP2302382A2 |
16575-EP2302383A2 |
16575-EP2305640A2 |
16575-EP2305652A2 |
16575-EP2305663A1 |
16575-EP2305688A1 |
16575-EP2305689A1 |
16575-EP2305695A2 |
16575-EP2305696A2 |
16575-EP2305697A2 |
16575-EP2305698A2 |
16575-EP2308844A2 |
16575-EP2308845A2 |
16575-EP2308846A2 |
16575-EP2311453A1 |
16575-EP2311806A2 |
16575-EP2316459A1 |
29474-EP2272827A1 |
29474-EP2277867A2 |
29474-EP2280003A2 |
29474-EP2292088A1 |
29474-EP2292611A1 |
29474-EP2295410A1 |
29474-EP2301939A1 |
29474-EP2311842A2 |
AB00173347-03 |
AB00173347_04 |
L-Glutamine, ReagentPlus(R), >=99% (HPLC) |
L-Glutamine, Vetec(TM) reagent grade, >=99% |
008G044 |
141066-EP2269996A1 |
141066-EP2292625A1 |
A831906 |
A937790 |
Q181619 |
7FBA778C-D6B8-495C-BFE7-1CB8EC4ABEAB |
J-521645 |
Q-100459 |
BRD-K83896451-001-01-8 |
F0001-1471 |
L-Glutamine, certified reference material, TraceCERT(R) |
Z1250208676 |
UNII-0O72R8RF8A component ZDXPYRJPNDTMRX-VKHMYHEASA-N |
Glutamine, United States Pharmacopeia (USP) Reference Standard |
UNII-5L555N1902 component ZDXPYRJPNDTMRX-VKHMYHEASA-N |
L-Glutamine, gamma-irradiated, BioXtra, suitable for cell culture |
L-Glutamine, Pharmaceutical Secondary Standard; Certified Reference Material |
L-Glutamine Solution 200 mM, 29.23 mg/mL in saline, solution, suitable for cell culture |
L-Glutamine solution, 200 mM, Hybri-Max(TM), sterile-filtered, suitable for hybridoma |
L-Glutamine solution, 200 mM, solution, sterile-filtered, BioXtra, suitable for cell culture |
L-Glutamine, meets USP testing specifications, cell culture tested, 99.0-101.0%, from non-animal source |
L-Glutamine, PharmaGrade, Ajinomoto, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture |
Experimental Data
L-glutamine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 5.000000000000000 | mM | 16.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 1.000000000000000 | mM | 15.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 10.000000000000000 | mM | -6.000000000000000 | S | N2 | 25643626 | Inactive | ||||||
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -3.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
L-glutamine
Statistics Data
L-glutamine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 16.000000000000000 | 2 | 4 |
Statistics Data Visualization
L-glutamine
